|
Fibrillation
|
0.100 |
Biomarker
|
disease |
BEFREE |
Engaging Raman microscopy, we made a critical structural analysis of oligomer and other assembly structures of lysozyme obtained from hen egg white and, provided a quantitative estimation of protein secondary structure in different states of its fibrillation.
|
31820990 |
2020 |
|
Fibrillation
|
0.100 |
Biomarker
|
disease |
BEFREE |
Bacopa monnieri inhibit hen egg white lysozyme fibrillation and help in retaining its activity at acidic condition.
|
31084353 |
2020 |
|
Fibrillation
|
0.100 |
Biomarker
|
disease |
BEFREE |
Proline functionalized gold nanoparticles modulates lysozyme fibrillation.
|
30476794 |
2019 |
|
Fibrillation
|
0.100 |
Biomarker
|
disease |
BEFREE |
Effect of Silica Nanoparticles on the Amyloid Fibrillation of Lysozyme.
|
31459377 |
2019 |
|
Fibrillation
|
0.100 |
Biomarker
|
disease |
BEFREE |
Mono-, di- and tri-carboxylic acids (acetic, lactic, levulinic, malic and citric acids) were used to prepare different DES formulations, which were successfully used on the fibrillation of lysozyme.
|
29596936 |
2018 |
|
Fibrillation
|
0.100 |
Biomarker
|
disease |
BEFREE |
The results show that pyrogallol, and 3,4-dihydroxy benzoic acid, each containing the o-dihydroxy moiety exhibited a significant inhibitory effect on lysozyme fibrillation which is further supported by docking studies.
|
29277421 |
2018 |
|
Fibrillation
|
0.100 |
Biomarker
|
disease |
BEFREE |
Benefiting from the enhanced solubility of 3.32×10<sup>-2</sup>g/mL for MLC and 4.66×10<sup>-2</sup>g/mL for DLC, the inhibition effects of the as-prepared derivatives on the amyloid fibrillation of lysozyme (HEWL) were investigated detaily in water solution.
|
28915469 |
2018 |
|
Fibrillation
|
0.100 |
Biomarker
|
disease |
BEFREE |
Inhibition of Lysozyme Fibrillation by Gold Nanorods and Nanoparticles.
|
29442807 |
2018 |
|
Fibrillation
|
0.100 |
Biomarker
|
disease |
BEFREE |
The data, altogether, suggest that the presence of ZnONP interface resulted in conformational rearrangements in the partially disordered lysozyme at pH 9.0 causing accumulation of non-amyloidogenic and functionally active intermediates, thus shielding the lysozyme from SDS induced fibrillation and cytotoxicity.
|
29778879 |
2018 |
|
Fibrillation
|
0.100 |
Biomarker
|
disease |
BEFREE |
The prepared lysozyme amyloid fibrils as well as their mixtures with in-lab synthesized magnetic particles, which were prepared by adding the nanoparticles to the fibrils solution after the process of fibrillation was done, were characterized using brightfield trans-illumination-mode optical microscope, atomic force microscopy (AFM) and scanning electron microscope (SEM).
|
29128831 |
2018 |
|
Fibrillation
|
0.100 |
Biomarker
|
disease |
BEFREE |
Paclitaxel inhibited lysozyme fibrillation, and interacted with lysozyme through hydrogen bonds and van der Waals' interactions.
|
29352977 |
2018 |
|
Fibrillation
|
0.100 |
Biomarker
|
disease |
BEFREE |
Tannic Acid-Induced Surface-Catalyzed Secondary Nucleation during the Amyloid Fibrillation of Hen Egg-White Lysozyme.
|
30545098 |
2018 |
|
Fibrillation
|
0.100 |
Biomarker
|
disease |
BEFREE |
Gallic acid induced dose dependent inhibition of lysozyme fibrillation.
|
28579468 |
2017 |
|
Fibrillation
|
0.100 |
Biomarker
|
disease |
BEFREE |
Oxidized epigallocatechin gallate inhibited lysozyme fibrillation more strongly than the native form.
|
28038426 |
2017 |
|
Fibrillation
|
0.100 |
Biomarker
|
disease |
BEFREE |
The results also suggested that the differences in the initial protein conformation might alter the mechanism of fibrillation; however, at the higher protein concentrations lysozyme shifted to nucleation-dependent pathway.
|
28448956 |
2017 |
|
Fibrillation
|
0.100 |
Biomarker
|
disease |
BEFREE |
At low heparin concentrations, initial hen egg white lysozyme cluster formation and subsequent fibrillation is promoted by counter ion binding and screening of repulsive charges.
|
29101231 |
2017 |
|
Fibrillation
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our in vitro and cell culture results establish the ability of calnuc to inhibit fibrillation of insulin and lysozyme and validate its neuroprotective role in cells treated with amyloid fibrils.
|
27997158 |
2017 |
|
Fibrillation
|
0.100 |
Biomarker
|
disease |
BEFREE |
This work investigates the effect of the fibrillation and/or adsorption onto a layered double hydroxide material on the antibacterial properties of lysozyme.
|
28554056 |
2017 |
|
Fibrillation
|
0.100 |
Biomarker
|
disease |
BEFREE |
In addition, neither GO nor RGO induced the fibrillation of lysozyme after 12d incubation.
|
28324692 |
2017 |
|
Fibrillation
|
0.100 |
Biomarker
|
disease |
BEFREE |
Amaranth delayed lysozyme fibrillation at 25 μM, while tartrazine had no effect even at 100 μM.
|
28094527 |
2017 |